ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.062,38
3,28%
S&P 500
5.778,15
-1,22%
Dow Jones
42.520,99
0,00%
Euro vs US Dollar
1,07016
0,73%
Bitcoin
90.373,57
3,60%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aadi Bioscience Inc (AADI)

  7. Aadi Bioscience Inc (AADI) News

AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AADI
DatumZeitQuelleÜberschriftSymbolFirma
05/03/202500h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
05/03/202500h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
05/03/202500h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
04/03/202523h58Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AADIAadi Bioscience Inc
04/03/202522h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AADIAadi Bioscience Inc
04/03/202522h05PR Newswire (US)Aadi Bioscience Announces Closing of $100 Million PIPE FinancingNASDAQ:AADIAadi Bioscience Inc
04/03/202502h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
04/03/202502h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
04/03/202502h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
04/03/202502h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
04/03/202502h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AADIAadi Bioscience Inc
03/03/202514h00PR Newswire (US)Aadi Bioscience Announces Approval of All Proposals at Special Meeting of StockholdersNASDAQ:AADIAadi Bioscience Inc
24/02/202514h00PR Newswire (US)Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare ConferenceNASDAQ:AADIAadi Bioscience Inc
19/02/202523h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AADIAadi Bioscience Inc
18/02/202522h58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
18/02/202522h22Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AADIAadi Bioscience Inc
18/02/202514h00PR Newswire (US)Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific OfficerNASDAQ:AADIAadi Bioscience Inc
14/02/202518h11Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AADIAadi Bioscience Inc
05/02/202522h49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AADIAadi Bioscience Inc
05/02/202522h05PR Newswire (US)Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025NASDAQ:AADIAadi Bioscience Inc
31/01/202523h09Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AADIAadi Bioscience Inc
30/01/202501h01Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AADIAadi Bioscience Inc
24/01/202520h34Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AADIAadi Bioscience Inc
21/01/202522h54Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:AADIAadi Bioscience Inc
30/12/202423h04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AADIAadi Bioscience Inc
23/12/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
23/12/202423h34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AADIAadi Bioscience Inc
23/12/202423h26Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AADIAadi Bioscience Inc
23/12/202421h51Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AADIAadi Bioscience Inc
20/12/202412h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AADIAadi Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:AADI

Kürzlich von Ihnen besucht

BIT
SFL
Safilo
NYSE
ASPN
Aspen Aerogels
NYSE
SFL
SFL
NASDAQ
NVCT
Nuvectis Pharma
NYSE
PACD
Pacific Drilling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten